MwanzoEMCURE • NSE
add
Emcure Pharmaceuticals Ltd
Bei iliyotangulia
₹ 1,364.40
Bei za siku
₹ 1,354.00 - ₹ 1,373.35
Bei za mwaka
₹ 1,225.00 - ₹ 1,580.00
Thamani ya kampuni katika soko
248.48B INR
Wastani wa hisa zilizouzwa
elfu 122.73
Uwiano wa bei na mapato
44.91
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
TheStreet
saa 4 zilizopita
The Trump Trade rally has stocks at record highs. Where do we go from here?
0.56%
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 20.02B | 20.38% |
Matumizi ya uendeshaji wa biashara | 9.29B | 17.93% |
Mapato halisi | 1.95B | 39.82% |
Kiwango cha faida halisi | 9.72 | 16.13% |
Mapato kwa kila hisa | 10.33 | — |
EBITDA | 3.79B | 19.19% |
Asilimia ya kodi ya mapato | 26.28% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.32B | -57.14% |
Jumla ya mali | 81.24B | 20.99% |
Jumla ya dhima | 38.21B | 0.54% |
Jumla ya hisa | 43.03B | — |
hisa zilizosalia | 188.36M | — |
Uwiano wa bei na thamani | 6.24 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 12.97% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.95B | 39.82% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
16 Apr 1981
Tovuti
Wafanyakazi
11,146
